YAŞAR, Ü. 2018. Does celecoxib inhibit agomelatine metabolism via CYP2C9 or CYP1A2?. DRUG DESIGN DEVELOPMENT AND THERAPY , vol.12 , 2169-2170.

YAŞAR, Ü., (2018). Does celecoxib inhibit agomelatine metabolism via CYP2C9 or CYP1A2?. DRUG DESIGN DEVELOPMENT AND THERAPY , vol.12, 2169-2170.

YAŞAR, ÜMİT. "Does celecoxib inhibit agomelatine metabolism via CYP2C9 or CYP1A2?," DRUG DESIGN DEVELOPMENT AND THERAPY , vol.12, 2169-2170, 2018

YAŞAR, ÜMİT. "Does celecoxib inhibit agomelatine metabolism via CYP2C9 or CYP1A2?." DRUG DESIGN DEVELOPMENT AND THERAPY , vol.12, pp.2169-2170, 2018

YAŞAR, Ü. (2018) . "Does celecoxib inhibit agomelatine metabolism via CYP2C9 or CYP1A2?." DRUG DESIGN DEVELOPMENT AND THERAPY , vol.12, pp.2169-2170.

@article{article, author={ÜMİT YAŞAR}, title={Does celecoxib inhibit agomelatine metabolism via CYP2C9 or CYP1A2?}, journal={DRUG DESIGN DEVELOPMENT AND THERAPY}, year=2018, pages={2169-2170} }